Vanda Pharmaceuticals (VM4.F) Q1 2026 Earnings

Feb 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-2.01
-1.45
-0.88
-0.31

Details

Expected EPS
-0.821028
Actual EPS
-2.0125712
Surprise EPS
-1.19
Surprise Percent
-145.13%

Description

⁨Vanda Pharmaceuticals⁩ (⁦VM4.F⁩) has reported earnings of ⁦-2.0125712⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts